HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

rilotumumab

a fully human monoclonal antibody that binds to hepatocyte growth factor (HGF), a potential cancer therapeutic agent because of its ability to disrupt HGF/c-Met signaling pathways which have been implicated in most tumor types
Also Known As:
AMG 102; AMG-102; AMG102
Networked: 25 relevant articles (6 outcomes, 17 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Oliner, Kelly S: 9 articles (06/2015 - 01/2010)
2. Zhu, Min: 8 articles (06/2015 - 01/2010)
3. Burgess, Teresa L: 7 articles (05/2013 - 11/2007)
4. Loh, Elwyn: 6 articles (06/2015 - 04/2011)
5. Coxon, Angela: 6 articles (05/2013 - 11/2007)
6. Anderson, Abraham: 5 articles (08/2014 - 01/2010)
7. Tang, Rui: 3 articles (08/2014 - 01/2013)
8. Deng, Hongjie: 3 articles (08/2014 - 01/2010)
9. Rex, Karen: 3 articles (05/2013 - 11/2007)
10. Sun, Jan: 3 articles (02/2010 - 11/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Stomach Neoplasms (Stomach Cancer)
3. Adenocarcinoma
4. Glioblastoma (Glioblastoma Multiforme)
5. Venous Thrombosis (Deep-Vein Thrombosis)

Related Drugs and Biologics

1. Cisplatin (Platino)
2. capecitabine (Xeloda)
3. Epirubicin (Ellence)
4. Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
5. Carbon Monoxide
6. Immunoglobulins (Immunoglobulin)
7. rilotumumab
8. panitumumab (Vectibix)
9. Prednisone (Sone)
10. Mitoxantrone (Novantrone)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Castration
3. Combination Drug Therapy (Combination Chemotherapy)
4. Drug Therapy (Chemotherapy)
5. Aftercare (After-Treatment)